Taylor dispersion analysis for measurement of diffusivity and size of gadolinium-based contrast agents

被引:2
|
作者
Somnin, Chutintorn [1 ]
Leclercq, Laurent [1 ]
Chamieh, Joseph [1 ]
Le Menedeu, Mael [2 ,3 ]
Medina, Christelle [2 ]
Rousseaux, Olivier [2 ]
Tripier, Raphael [3 ]
Iglesias, Carlos Platas [4 ,5 ]
Corret, Herve [1 ]
机构
[1] Univ Montpellier, CNRS, IBMM, ENSCM, Montpellier, France
[2] CDG, GUERBET Res &Innovat, BP57400, F-95943 Roissy, France
[3] Univ Brest, UMR CNRS CEMCA 6521, F-29238 Brest, France
[4] Univ A Coruna, Facultaded Ciencias, La Coruna 15008, Spain
[5] Univ A Coruna, CICA, La Coruna 15008, Spain
关键词
Taylor dispersion analysis; Diffusion coefficient; Hydrodynamic diameter; Gadolinium-based contrast agents; Magnetic resonance imaging agents; INTRAVENOUS-INJECTION; PHARMACOKINETICS; ELECTROPHORESIS; TOLERABILITY; COEFFICIENT; COMPLEXES; MOLECULES; SOLUTE;
D O I
10.1016/j.ejps.2024.106831
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Gadolinium-based contrast agents (GBCA) are complexes of a Gadolinium metal center and a linear or macrocyclic polyamino-carboxylic acid chelating agent. These agents are employed to enhance the visibility of deep abnormalities through MRI techniques. Knowing the precise dimensions of various GBCA is key parameter for understanding their in-vivo and pharmaco-kinetic behaviors, their diffusivity, as well as their relaxivity. However, conventional size characterization techniques fall short when dealing with these tiny molecules (<= 1 nm). In this work, we propose to determine the size and diffusivity of gadolinium-based contrast agents using Taylor dispersion analysis (TDA). TDA provided a reliable measurement of the hydrodynamic diameter and the diffusion coefficient. The obtained results were compared to DOSY NMR (Diffusion-ordered Nuclear Magnetic Resonance Spectroscopy) and DFT (Density Functional Theory).
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Gadolinium-based contrast agents: From gadolinium complexes to colloidal systems
    Yon, Marjorie
    Billotey, Claire
    Marty, Jean-Daniel
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2019, 569
  • [32] A greener approach toward gadolinium-based contrast agents
    Gazzi, Thais P.
    Basso, Luiz A.
    Santos, Diogenes S.
    Machado, Pablo
    RSC ADVANCES, 2014, 4 (19): : 9880 - 9884
  • [33] Gadolinium-Based Contrast Agents Associated Adverse Reactions
    Ramalho, Miguel
    Ramaiho, Joana
    MAGNETIC RESONANCE IMAGING CLINICS OF NORTH AMERICA, 2017, 25 (04) : 755 - +
  • [34] Nephrogenic Systemic Fibrosis and Gadolinium-Based Contrast Agents
    Abu-Alfa, Ali K.
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2011, 18 (03) : 188 - 198
  • [35] Gadolinium-based Contrast Agents: Patient Safety Concerns
    Foster-Bollman, Christy
    Mackey, Tim K.
    RADIOLOGIC TECHNOLOGY, 2016, 87 (05) : 552M - 556M
  • [37] A Reality Check on Intrathecal Gadolinium-based Contrast Agents
    Kanal, Emanuel
    RADIOLOGY, 2020, 297 (01) : 84 - 86
  • [38] Greener approach toward gadolinium-based contrast agents
    Gazzi, Thais P.
    Basso, Luiz A.
    Santos, Diogenes S.
    Machado, Pablo
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248
  • [39] Pharmaceutical and safety aspects of gadolinium-based contrast agents
    Sieber, Martin A.
    EJHP PRACTICE, 2009, 15 (06): : 24 - 27
  • [40] Administration of Gadolinium-Based Contrast Agents in MR Angiography
    Lin, Kai
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2009, 192 (04) : W193 - W193